Certain Options of IperionX Limited are subject to a Lock-Up Agreement Ending on 6-SEP-2026.

IperionX Limited's options are under a 61-day lock-up agreement ending on 6-SEP-2026. Officers, directors, and certain securityholders agreed not to trade these options during this period. IperionX is a titanium and critical materials company with projects in the U.S. The company focuses on low-energy, low-carbon titanium production for various industries.

Original reporting
Published Sep 6, 2026, 12:36 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 7, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$IPX
Relevance
4/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

Low
01

Why it matters

The lock‑up agreement restricts option holders from selling for 61 days, limiting short‑term supply of shares.

02

Market read

A routine corporate filing with limited trading impact.

03

What to watch

Potential future dilution if options are exercised after lock‑up.

Relevance 4/10Novelty 4/10Timing: lock‑up period 7‑Jul‑2026 to 6‑Sep‑2026

Background

IperionX Limited is a titanium and critical materials company developing titanium alloys and mineral projects in Tennessee.

Market effects

minimal impact on titanium/critical minerals sector

none

none

Counterpoint

Lock‑up terms are standard and unlikely to move price.

Key entities

  • IperionX Limited

    Titanium metal and critical materials producer.

Related articles

$IPXMedAI 8/10

IperionX Raises $50 Million to Expand U.S. Titanium Production - 3DPrint.com

IperionX raised about $50 million via a public offering, selling 2.275 million shares at $21.98 each, to expand U.S. titanium manufacturing. The company plans to increase capacity in Virginia, continue its Tennessee Camden Titanium Project, and fund low-carbon titanium R&D, according to the company. Cantor Fitzgerald led, with Roth Capital Partners and B. Riley Securities co-managing.

$VODMed

EasyJet, Vodafone & Picton: Markets live

Apollo Global Management raised its easyJet (EZJ) cash offer to 715p per share, valuing the airline at £5.7bn, and easyJet’s board said it is minded to recommend. The bid is 25p higher than Castlelake’s. Other updates: MJ Gleeson (GLE) expects results in line but outlook uncertain; Impax (IPX) AUM rose to £23.3bn; Vodafone (VOD) gets e& stake sold to Xavier Niel; Schroder REIT (SREI) bid for Picton (PCTN); Hays (HAS) profit guidance; Johnson Service Group (JSG) shares fall.

$IPXHighAI 10/10

IperionX Shares Dive Following Capital Raise: The Details

IperionX (ASX:IPX) shares fell 14.14% to A$3.46 after the company priced an underwritten public offering of 2.275m ADS at US$21.98 each, raising about US$50m gross. Each ADS equals 10 ordinary shares, implying 22.75m new shares and over 22m-share dilution. Proceeds fund Virginia expansion, R&D, Camden-Titan, and general purposes.

$IPXMed

IperionX Announces Pricing of Public Offering of American Depositary Shares – LiveNews.co.nz

IperionX Limited (Nasdaq:IPX; ASX:IPX) priced an underwritten public offering of 2,275,000 ADSs at $21.98 per ADS, raising about $50 million in gross proceeds, before underwriting and offering expenses. Each ADS represents 10 ordinary shares. Proceeds will fund titanium technology commercialization, Virginia campus scale-up, Tennessee Camden-Titan development, and general corporate purposes; closing is expected July 9, 2026.